The Analyst Verdict: Houlihan Lokey In The Eyes Of 5 Experts

In the preceding three months, 5 analysts have released ratings for Houlihan Lokey HLI, presenting a wide array of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 4 1 0 0
Last 30D 0 1 0 0 0
1M Ago 0 0 0 0 0
2M Ago 0 1 1 0 0
3M Ago 0 2 0 0 0

Analysts have set 12-month price targets for Houlihan Lokey, revealing an average target of $177.6, a high estimate of $192.00, and a low estimate of $156.00. This current average reflects an increase of 0.79% from the previous average price target of $176.20.

Analyzing Analyst Ratings: A Detailed Breakdown

In examining recent analyst actions, we gain insights into how financial experts perceive Houlihan Lokey. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Ryan Kenny Morgan Stanley Raises Overweight $192.00 $159.00
Aidan Hall Keefe, Bruyette & Woods Raises Market Perform $185.00 $183.00
Michael Brown Wells Fargo Raises Overweight $185.00 $170.00
Michael Brown Wells Fargo Lowers Overweight $170.00 $179.00
Ryan Kenny Morgan Stanley Lowers Overweight $156.00 $190.00

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Houlihan Lokey. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Houlihan Lokey compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Houlihan Lokey's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Houlihan Lokey's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Houlihan Lokey analyst ratings.

Get to Know Houlihan Lokey Better

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Houlihan Lokey: A Financial Overview

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Growth: Houlihan Lokey displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 28.05%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: Houlihan Lokey's net margin excels beyond industry benchmarks, reaching 18.29%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 5.73%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Houlihan Lokey's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.34% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: With a below-average debt-to-equity ratio of 0.2, Houlihan Lokey adopts a prudent financial strategy, indicating a balanced approach to debt management.

Analyst Ratings: What Are They?

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

HLI Logo
HLIHoulihan Lokey Inc
$177.152.41%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
78.03
Growth
95.90
Quality
87.87
Value
24.47
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...